Myeloid hematopoietic growth factors and their role in prevention and/or treatment of neonatal sepsis**
References (68)
- et al.
Sepsis syndrome and septic shock in pediatrics: Current concepts of terminology, pathophysiology and management
J Pediatr
(1993) - et al.
Early-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network
J Pediatrics
(1996) - et al.
Late-onset sepsis in very low birthweight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research Network
J Pediatr
(1996) - et al.
Intravenous immunoglobulin therapy for early-onset sepsis in premature neonates
J Pediatr
(1992) - et al.
Intravenous gamma globulin therapy for prophylaxis of infection in highrisk neonates
J Pediatr
(1987) - et al.
Use of intravenously administered immune globulin to prevent nosocomial sepsis in low birth weight infants: Report of a pilot study
J Pediatr
(1989) - et al.
Role of circulating complement and polymorphonuclear leukocyte transfusion in treatment and outcome in critically ill neonates with sepsis
J Pediatr
(1987) - et al.
Increased granulocyte-macrophage colony-stimulating factor mRNA instability in cord versus adult mononuclear cells is translation-dependent and associated with increased levels of AU-rich element binding factor
Blood
(1996) - et al.
Decreased macrophage colony-stimulating factor mRNA expression from activated cord versus adult mononuclear cells: altered post transcriptional stability
Blood
(1994) - et al.
Effect of murine mast cell growth factor (c-kit proto-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells
Blood
(1991)
Role of c-kit ligand in the expansion of human hematopoietic progenitor cells
Blood
(1992)
Recombinant human stem cell factor enhances the formation of colonies by CD34 and CD34 lin-cells, and the generation of colonyforming cell progeny from CD34 lin cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor
Blood
(1991)
Mast cell growth factor (c-kit ligand) supports the growth of human multipotential progenitor cells with a high replating potential
Blood
(1991)
Effect of stem cell factor with and without granulocyte colony-stimulating factor on neonatal hematopiesis: In vivo induction of newborn myelopoiesis and reduction of mortality during experimental group B streptococcal sepsis
Blood
(1992)
Transforming growth factor-β1, macrophage inflammatory protein-1α, and interleukin-8 gene expression is lower in stimulated human neonatal compared to adult mononuclear cells
Blood
(1994)
Seven-day administration of recombinant human granulocyte colony-stimulating factor to newborn rats: Modulation of neonatal neutrophilia, myelopoiesis, and group B streptococcus sepsis
Blood
(1990)
Endogenous interleukin-11 (IL-11) expression is increased and prophylactic use of exogenous IL-11 enhances platelet recovery and improves survival during thrombocytopenia associated with experimental group B streptococcal sepsis in neonatal rats
Blood Cells, Molecules, Dis
(1996)
Granulocyte-macrophage colony-stimulating factor enhances phagocytosis of bacteria by human neutrophils
Blood
(1986)
Abnormal stimulated adherence of neonatal granulocytes: impaired induction of surface Mac-1 by chemotactic factors or secretagogues
Blood
(1987)
A randomized, placebo-controlled trial of recombinant human granulocytecolony stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia
Blood
(1994)
Results of a phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in very low birthweight neonates: significant induction of circulatory neutrophils, monocytes, platelets and bone marrow neutrophils
Blood
(1995)
A randomized, doubleblind, placebo-controlled trial of prophylactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonates
J Pediatr
(1999)
Neonatal sepsis
Adv Pediatric Infect Dis
(1992)
Neonatal Sepsis. Progress in diagnosis and management
Drugs
(1988)
Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. I. Epidemiologic rationale
J Infect Dis
(1983)
Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis
N Engl J Med
(1986)
Immunoglobulin supplementation in prevention or treatment of neonatal sepsis
Pediatr Infect Dis
(1986)
IgM-enriched intravenous immunoglobulin therapy in neonatal sepsis
Am J Dis Child
(1988)
Intravenous gamma globulin as adjunct therapy for severe group B streptococcal disease in the newborn
Am J Perinatol
(1990)
A controlled trial of prophylactic intravenous immunoglobulin (IVIG) to reduce nosocomial infections in VLBW infants
Pediatr Res
(1992)
Intravenous immunoglobulin for prevention of sepsis in preterm and low birth weight infants
Pediatr Infect Dis
(1986)
Intravenous immune globulin for the prevention of nosocomial infection in low-birth-weight neonates. The Multicenter Group for the Study of Immune Globulin in Neonates
N Engl J Med
(1992)
Polymorphonuclear leukocyte transfusion for the treatment of sepsis in the newborn infant
J Pediatr
(1981)
Cited by (0)
- **
Supported in part by a grant from the Pediatric Cancer Research Foundation
Copyright © 2002 W.B. Saunders Company. Published by Elsevier Inc. All rights reserved.